Premium
Major noncardiac surgery following coronary stenting: When is it safe to operate?
Author(s) -
Sharma Arvind K.,
Ajani Andrew E.,
Hamwi Shadi M.,
Maniar Parimal,
Lakhani Shilen V.,
Waksman Ron,
Lindsay Joseph
Publication year - 2004
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.20124
Subject(s) - medicine , thienopyridine , perioperative , coronary stenting , surgery , stent , thrombosis , coronary stent , elective surgery , percutaneous coronary intervention , cardiology , myocardial infarction , restenosis
The optimal timing for elective noncardiac surgery (NCS) after coronary stenting is uncertain. We identified 47 patients who underwent elective NCS within 90 days of coronary stent placement between January 1995 and December 2000. Twenty‐seven patients had NCS within 3 weeks of coronary stenting. Six of the seven in whom thienopyridine antiplatelet therapy was discontinued died postoperatively in a manner suggestive of stent thrombosis. In contrast, only 1 of the 20 patients in whom the thienopyridine was continued through the NCS died. The frequency of perioperative hemorrhage was similar whether or not the antiplatelet agent was continued. Only 1 perioperative death occurred in the 20 patients with NCS more than 3 weeks following stenting. Catheter Cardiovasc Interv 2004;63:141–145. © 2004 Wiley‐Liss, Inc.